speb/financial-data huggingface dataset:
LXCHEM.NS balance_sheet (annual, 2023-03-31) — Other Current Assets: 3460000.00
LXCHEM.NS balance_sheet (annual, 2023-03-31) — Other Current Liabilities: 72280000.00
LXCHEM.NS balance_sheet (annual, 2023-03-31) — Other Equity Interest: 134080000.00
LXCHEM.NS balance_sheet (annual, 2023-03-31) — Other Intangible Assets: 4480000.00
LXCHEM.NS balance_sheet (annual, 2023-03-31) — Other Inventories: 16570000.00
LXCHEM.NS cash_flow (annual, 2023-03-31) — Other Non Cash Items: 14800000.00
LXCHEM.NS balance_sheet (annual, 2023-03-31) — Other Non Current Assets: -10000.00
LXCHEM.NS income_statement (annual, 2023-03-31) — Other Non Operating Income Expenses: 8150000.00
LXCHEM.NS income_statement (annual, 2023-03-31) — Other Operating Expenses: 3618950000.00
LXCHEM.NS balance_sheet (annual, 2023-03-31) — Other Payable: 337000000.00
LXCHEM.NS balance_sheet (annual, 2023-03-31) — Other Properties: 22310000.00
LXCHEM.NS balance_sheet (annual, 2023-03-31) — Other Receivables: 773970000.00
LXCHEM.NS balance_sheet (annual, 2023-03-31) — Other Short Term Investments: 657530000.00
LXCHEM.NS income_statement (annual, 2023-03-31) — Other Special Charges: -5680000.00
LXCHEM.NS income_statement (annual, 2023-03-31) — Otherunder Preferred Stock Dividend: 0.00
LXCHEM.NS balance_sheet (annual, 2023-03-31) — Payables: 5047320000.00
LXCHEM.NS balance_sheet (annual, 2023-03-31) — Prepaid Assets: 1236770000.00
LXCHEM.NS income_statement (annual, 2023-03-31) — Pretax Income: 1729130000.00
LXCHEM.NS balance_sheet (annual, 2023-03-31) — Properties: 0.00
LXCHEM.NS cash_flow (annual, 2023-03-31) — Provisionand Write Offof Assets: 62210000.00
LXCHEM.NS cash_flow (annual, 2023-03-31) — Purchase Of Business: -15120000.00
LXCHEM.NS cash_flow (annual, 2023-03-31) — Purchase Of Investment: -10049500000.00
LXCHEM.NS balance_sheet (annual, 2023-03-31) — Raw Materials: 2213270000.00
LXCHEM.NS income_statement (annual, 2023-03-31) — Reconciled Cost Of Revenue: 19067330000.00
LXCHEM.NS income_statement (annual, 2023-03-31) — Reconciled Depreciation: 725250000.00
LXCHEM.NS income_statement (annual, 2023-03-31) — Rent And Landing Fees: 12180000.00
LXCHEM.NS income_statement (annual, 2023-03-31) — Rent Expense Supplemental: 12180000.00
LXCHEM.NS cash_flow (annual, 2023-03-31) — Repayment Of Debt: -99760000.00
LXCHEM.NS balance_sheet (annual, 2023-03-31) — Restricted Cash: 40990000.00
LXCHEM.NS balance_sheet (annual, 2023-03-31) — Retained Earnings: 8359790000.00
LXCHEM.NS cash_flow (annual, 2023-03-31) — Sale Of Investment: 10884480000.00
LXCHEM.NS cash_flow (annual, 2023-03-31) — Sale Of PPE: 1450000.00
LXCHEM.NS income_statement (annual, 2023-03-31) — Selling And Marketing Expense: 1011070000.00
LXCHEM.NS income_statement (annual, 2023-03-31) — Selling General And Administration: 1395950000.00
LXCHEM.NS balance_sheet (annual, 2023-03-31) — Share Issued: 265176208.00
LXCHEM.NS cash_flow (annual, 2023-03-31) — Short Term Debt Issuance: 1331930000.00
LXCHEM.NS income_statement (annual, 2023-03-31) — Special Income Charges: 14000000.00
LXCHEM.NS cash_flow (annual, 2023-03-31) — Stock Based Compensation: 114170000.00
LXCHEM.NS balance_sheet (annual, 2023-03-31) — Stockholders Equity: 14117700000.00
LXCHEM.NS balance_sheet (annual, 2023-03-31) — Tangible Book Value: 14113220000.00
LXCHEM.NS income_statement (annual, 2023-03-31) — Tax Effect Of Unusual Items: 5891217.49
LXCHEM.NS income_statement (annual, 2023-03-31) — Tax Provision: 483010000.00
LXCHEM.NS income_statement (annual, 2023-03-31) — Tax Rate For Calcs: 0.28
LXCHEM.NS cash_flow (annual, 2023-03-31) — Taxes Refund Paid: -501410000.00
LXCHEM.NS balance_sheet (annual, 2023-03-31) — Total Assets: 24122010000.00
LXCHEM.NS balance_sheet (annual, 2023-03-31) — Total Capitalization: 15421100000.00
LXCHEM.NS balance_sheet (annual, 2023-03-31) — Total Debt: 4057190000.00
LXCHEM.NS balance_sheet (annual, 2023-03-31) — Total Equity Gross Minority Interest: 14123840000.00
LXCHEM.NS income_statement (annual, 2023-03-31) — Total Expenses: 26031290000.00
LXCHEM.NS balance_sheet (annual, 2023-03-31) — Total Liabilities Net Minority Interest: 9998170000.00
LXCHEM.NS balance_sheet (annual, 2023-03-31) — Total Non Current Assets: 11954540000.00
LXCHEM.NS balance_sheet (annual, 2023-03-31) — Total Non Current Liabilities Net Minority Interest: 1696980000.00
LXCHEM.NS income_statement (annual, 2023-03-31) — Total Other Finance Cost: 38410000.00
LXCHEM.NS balance_sheet (annual, 2023-03-31) — Total Tax Payable: 46970000.00
LXCHEM.NS income_statement (annual, 2023-03-31) — Total Unusual Items: 21090000.00
LXCHEM.NS income_statement (annual, 2023-03-31) — Total Unusual Items Excluding Goodwill: 21090000.00
LXCHEM.NS balance_sheet (annual, 2023-03-31) — Work In Process: 37830000.00
LXCHEM.NS balance_sheet (annual, 2023-03-31) — Working Capital: 3866280000.00
LXCHEM.NS income_statement (annual, 2023-03-31) — Write Off: -8320000.00
LXCHEM.NS income_statement (annual, 2024-03-31) — +Operating Expense: 7073560000.00
LXCHEM.NS income_statement (annual, 2024-03-31) — +Total Revenue: 28360750000.00
LXCHEM.NS balance_sheet (annual, 2024-03-31) — Accounts Payable: 7621250000.00
LXCHEM.NS balance_sheet (annual, 2024-03-31) — Accounts Receivable: 5834360000.00
LXCHEM.NS balance_sheet (annual, 2024-03-31) — Accumulated Depreciation: -4068680000.00
LXCHEM.NS balance_sheet (annual, 2024-03-31) — Additional Paid In Capital: 7770110000.00
LXCHEM.NS balance_sheet (annual, 2024-03-31) — Allowance For Doubtful Accounts Receivable: -24270000.00
LXCHEM.NS income_statement (annual, 2024-03-31) — Amortization: 2780000.00
LXCHEM.NS cash_flow (annual, 2024-03-31) — Amortization Cash Flow: 2780000.00
LXCHEM.NS balance_sheet (annual, 2024-03-31) — Available For Sale Securities: 460000.00
LXCHEM.NS income_statement (annual, 2024-03-31) — Basic Average Shares: 270186276.00
LXCHEM.NS income_statement (annual, 2024-03-31) — Basic EPS: 4.46
LXCHEM.NS cash_flow (annual, 2024-03-31) — Beginning Cash Position: 810140000.00
LXCHEM.NS balance_sheet (annual, 2024-03-31) — Buildings And Improvements: 2610890000.00
LXCHEM.NS cash_flow (annual, 2024-03-31) — Capital Expenditure: -2476670000.00
LXCHEM.NS cash_flow (annual, 2024-03-31) — Capital Expenditure Reported: -2476670000.00
LXCHEM.NS balance_sheet (annual, 2024-03-31) — Capital Lease Obligations: 70380000.00
LXCHEM.NS balance_sheet (annual, 2024-03-31) — Capital Stock: 551560000.00
LXCHEM.NS balance_sheet (annual, 2024-03-31) — Cash And Cash Equivalents: 1111390000.00
LXCHEM.NS balance_sheet (annual, 2024-03-31) — Cash Cash Equivalents And Short Term Investments: 4208440000.00
LXCHEM.NS cash_flow (annual, 2024-03-31) — Cash Dividends Paid: -132790000.00
LXCHEM.NS balance_sheet (annual, 2024-03-31) — Cash Equivalents: 610000000.00
LXCHEM.NS balance_sheet (annual, 2024-03-31) — Cash Financial: 501390000.00
LXCHEM.NS cash_flow (annual, 2024-03-31) — Change In Inventory: 108780000.00
LXCHEM.NS cash_flow (annual, 2024-03-31) — Change In Other Current Assets: 327210000.00
LXCHEM.NS cash_flow (annual, 2024-03-31) — Change In Other Current Liabilities: -169430000.00
LXCHEM.NS cash_flow (annual, 2024-03-31) — Change In Payable: 2962250000.00
LXCHEM.NS cash_flow (annual, 2024-03-31) — Change In Receivables: -171420000.00
LXCHEM.NS cash_flow (annual, 2024-03-31) — Change In Working Capital: 3086130000.00
LXCHEM.NS cash_flow (annual, 2024-03-31) — Changes In Cash: 301250000.00
LXCHEM.NS balance_sheet (annual, 2024-03-31) — Common Stock: 551560000.00
LXCHEM.NS cash_flow (annual, 2024-03-31) — Common Stock Dividend Paid: -132790000.00
LXCHEM.NS balance_sheet (annual, 2024-03-31) — Common Stock Equity: 17976210000.00
LXCHEM.NS cash_flow (annual, 2024-03-31) — Common Stock Issuance: 2675670000.00
LXCHEM.NS balance_sheet (annual, 2024-03-31) — Construction In Progress: 4523750000.00
LXCHEM.NS income_statement (annual, 2024-03-31) — Cost Of Revenue: 19838230000.00
LXCHEM.NS balance_sheet (annual, 2024-03-31) — Current Assets: 14772360000.00
LXCHEM.NS balance_sheet (annual, 2024-03-31) — Current Capital Lease Obligation: 6260000.00
LXCHEM.NS balance_sheet (annual, 2024-03-31) — Current Debt: 385220000.00
LXCHEM.NS balance_sheet (annual, 2024-03-31) — Current Debt And Capital Lease Obligation: 391480000.00
LXCHEM.NS balance_sheet (annual, 2024-03-31) — Current Deferred Taxes Liabilities: 187360000.00
LXCHEM.NS balance_sheet (annual, 2024-03-31) — Current Liabilities: 8911280000.00
LXCHEM.NS balance_sheet (annual, 2024-03-31) — Current Provisions: 49770000.00
LXCHEM.NS cash_flow (annual, 2024-03-31) — Depreciation: 1073300000.00
LXCHEM.NS cash_flow (annual, 2024-03-31) — Depreciation And Amortization: 1076080000.00
LXCHEM.NS income_statement (annual, 2024-03-31) — Depreciation And Amortization In Income Statement: 1065920000.00
LXCHEM.NS income_statement (annual, 2024-03-31) — Depreciation Income Statement: 1063140000.00
LXCHEM.NS income_statement (annual, 2024-03-31) — Diluted Average Shares: 272172130.00
LXCHEM.NS income_statement (annual, 2024-03-31) — Diluted EPS: 4.43
LXCHEM.NS income_statement (annual, 2024-03-31) — Diluted NI Availto Com Stockholders: 1205350000.00
LXCHEM.NS income_statement (annual, 2024-03-31) — EBIT: 1768700000.00
LXCHEM.NS income_statement (annual, 2024-03-31) — EBITDA: 2844780000.00
LXCHEM.NS cash_flow (annual, 2024-03-31) — End Cash Position: 1111390000.00
LXCHEM.NS balance_sheet (annual, 2024-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 0.00
LXCHEM.NS cash_flow (annual, 2024-03-31) — Financing Cash Flow: -416210000.00
LXCHEM.NS balance_sheet (annual, 2024-03-31) — Finished Goods: 628710000.00
LXCHEM.NS cash_flow (annual, 2024-03-31) — Free Cash Flow: 3136180000.00
LXCHEM.NS cash_flow (annual, 2024-03-31) — Gain Loss On Investment Securities: -43260000.00
LXCHEM.NS cash_flow (annual, 2024-03-31) — Gain Loss On Sale Of PPE: -1870000.00
LXCHEM.NS income_statement (annual, 2024-03-31) — General And Administrative Expense: 533790000.00
LXCHEM.NS balance_sheet (annual, 2024-03-31) — Goodwill And Other Intangible Assets: 13180000.00
LXCHEM.NS balance_sheet (annual, 2024-03-31) — Gross Accounts Receivable: 5858630000.00
LXCHEM.NS balance_sheet (annual, 2024-03-31) — Gross PPE: 17366660000.00
LXCHEM.NS income_statement (annual, 2024-03-31) — Gross Profit: 8522520000.00
LXCHEM.NS income_statement (annual, 2024-03-31) — Interest Expense: 60750000.00
LXCHEM.NS income_statement (annual, 2024-03-31) — Interest Expense Non Operating: 60750000.00
LXCHEM.NS income_statement (annual, 2024-03-31) — Interest Income: 142580000.00
LXCHEM.NS income_statement (annual, 2024-03-31) — Interest Income Non Operating: 142580000.00
LXCHEM.NS cash_flow (annual, 2024-03-31) — Interest Paid Cff: -208920000.00
LXCHEM.NS cash_flow (annual, 2024-03-31) — Interest Received Cfi: 127870000.00
LXCHEM.NS balance_sheet (annual, 2024-03-31) — Inventory: 2833360000.00
LXCHEM.NS balance_sheet (annual, 2024-03-31) — Invested Capital: 19333670000.00
LXCHEM.NS cash_flow (annual, 2024-03-31) — Investing Cash Flow: -4895390000.00
LXCHEM.NS balance_sheet (annual, 2024-03-31) — Investmentin Financial Assets: 460000.00
LXCHEM.NS balance_sheet (annual, 2024-03-31) — Investmentsin Associatesat Cost: 27620000.00
LXCHEM.NS cash_flow (annual, 2024-03-31) — Issuance Of Capital Stock: 2675670000.00
LXCHEM.NS cash_flow (annual, 2024-03-31) — Issuance Of Debt: 0.00
LXCHEM.NS balance_sheet (annual, 2024-03-31) — Land And Improvements: 1446520000.00
LXCHEM.NS balance_sheet (annual, 2024-03-31) — Long Term Capital Lease Obligation: 64120000.00
LXCHEM.NS balance_sheet (annual, 2024-03-31) — Long Term Debt: 972240000.00
LXCHEM.NS balance_sheet (annual, 2024-03-31) — Long Term Debt And Capital Lease Obligation: 1036360000.00
LXCHEM.NS cash_flow (annual, 2024-03-31) — Long Term Debt Issuance: 0.00
LXCHEM.NS cash_flow (annual, 2024-03-31) — Long Term Debt Payments: -96600000.00
LXCHEM.NS balance_sheet (annual, 2024-03-31) — Long Term Equity Investment: 27620000.00
LXCHEM.NS balance_sheet (annual, 2024-03-31) — Long Term Provisions: 61190000.00
LXCHEM.NS balance_sheet (annual, 2024-03-31) — Machinery Furniture Equipment: 8763190000.00
LXCHEM.NS balance_sheet (annual, 2024-03-31) — Minority Interest: 3710000.00
LXCHEM.NS income_statement (annual, 2024-03-31) — Minority Interests: 0.00
LXCHEM.NS cash_flow (annual, 2024-03-31) — Net Business Purchase And Sale: 0.00
LXCHEM.NS cash_flow (annual, 2024-03-31) — Net Common Stock Issuance: 2675670000.00
LXCHEM.NS balance_sheet (annual, 2024-03-31) — Net Debt: 246070000.00
LXCHEM.NS cash_flow (annual, 2024-03-31) — Net Foreign Currency Exchange Gain Loss: 42200000.00
LXCHEM.NS income_statement (annual, 2024-03-31) — Net Income: 1205350000.00
LXCHEM.NS income_statement (annual, 2024-03-31) — Net Income Common Stockholders: 1205350000.00
LXCHEM.NS income_statement (annual, 2024-03-31) — Net Income Continuous Operations: 1205350000.00
LXCHEM.NS income_statement (annual, 2024-03-31) — Net Income From Continuing And Discontinued Operation: 1205350000.00
LXCHEM.NS income_statement (annual, 2024-03-31) — Net Income From Continuing Operation Net Minority Interest: 1205350000.00
LXCHEM.NS cash_flow (annual, 2024-03-31) — Net Income From Continuing Operations: 1707950000.00
LXCHEM.NS income_statement (annual, 2024-03-31) — Net Income Including Noncontrolling Interests: 1205350000.00
LXCHEM.NS income_statement (annual, 2024-03-31) — Net Interest Income: 77100000.00
LXCHEM.NS cash_flow (annual, 2024-03-31) — Net Investment Purchase And Sale: -2548460000.00
LXCHEM.NS cash_flow (annual, 2024-03-31) — Net Issuance Payments Of Debt: -2612250000.00
LXCHEM.NS cash_flow (annual, 2024-03-31) — Net Long Term Debt Issuance: -96600000.00
LXCHEM.NS income_statement (annual, 2024-03-31) — Net Non Operating Interest Income Expense: 77100000.00
LXCHEM.NS cash_flow (annual, 2024-03-31) — Net Other Financing Charges: -2430000.00
LXCHEM.NS cash_flow (annual, 2024-03-31) — Net Other Investing Changes: -10000.00
LXCHEM.NS balance_sheet (annual, 2024-03-31) — Net PPE: 13297980000.00
LXCHEM.NS cash_flow (annual, 2024-03-31) — Net PPE Purchase And Sale: 1870000.00
LXCHEM.NS cash_flow (annual, 2024-03-31) — Net Short Term Debt Issuance: -2515650000.00
LXCHEM.NS balance_sheet (annual, 2024-03-31) — Net Tangible Assets: 17963030000.00
LXCHEM.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Taxes Liabilities: 283460000.00
LXCHEM.NS balance_sheet (annual, 2024-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 61190000.00
LXCHEM.NS balance_sheet (annual, 2024-03-31) — Non Current Prepaid Assets: 151840000.00
LXCHEM.NS income_statement (annual, 2024-03-31) — Normalized EBITDA: 2640240000.00
LXCHEM.NS income_statement (annual, 2024-03-31) — Normalized Income: 1061000171.84
LXCHEM.NS cash_flow (annual, 2024-03-31) — Operating Cash Flow: 5612850000.00
LXCHEM.NS income_statement (annual, 2024-03-31) — Operating Income: 1448960000.00
LXCHEM.NS income_statement (annual, 2024-03-31) — Operating Revenue: 28360750000.00
LXCHEM.NS balance_sheet (annual, 2024-03-31) — Ordinary Shares Number: 275780785.00
LXCHEM.NS balance_sheet (annual, 2024-03-31) — Other Current Assets: 10000.00
LXCHEM.NS balance_sheet (annual, 2024-03-31) — Other Current Liabilities: 220000.00
LXCHEM.NS balance_sheet (annual, 2024-03-31) — Other Equity Interest: 141790000.00
LXCHEM.NS balance_sheet (annual, 2024-03-31) — Other Intangible Assets: 13180000.00
LXCHEM.NS balance_sheet (annual, 2024-03-31) — Other Inventories: 17820000.00
LXCHEM.NS cash_flow (annual, 2024-03-31) — Other Non Cash Items: -91670000.00
LXCHEM.NS balance_sheet (annual, 2024-03-31) — Other Non Current Assets: -10000.00
LXCHEM.NS income_statement (annual, 2024-03-31) — Other Non Operating Income Expenses: 15870000.00
LXCHEM.NS income_statement (annual, 2024-03-31) — Other Operating Expenses: 3378500000.00
LXCHEM.NS balance_sheet (annual, 2024-03-31) — Other Payable: 406810000.00
LXCHEM.NS balance_sheet (annual, 2024-03-31) — Other Properties: 22310000.00
LXCHEM.NS balance_sheet (annual, 2024-03-31) — Other Receivables: 415820000.00
LXCHEM.NS balance_sheet (annual, 2024-03-31) — Other Short Term Investments: 3097050000.00
LXCHEM.NS income_statement (annual, 2024-03-31) — Other Special Charges: -233110000.00
LXCHEM.NS income_statement (annual, 2024-03-31) — Otherunder Preferred Stock Dividend: 0.00
LXCHEM.NS balance_sheet (annual, 2024-03-31) — Payables: 8028060000.00
LXCHEM.NS balance_sheet (annual, 2024-03-31) — Prepaid Assets: 1287170000.00
LXCHEM.NS income_statement (annual, 2024-03-31) — Pretax Income: 1707950000.00
LXCHEM.NS balance_sheet (annual, 2024-03-31) — Properties: 0.00
LXCHEM.NS cash_flow (annual, 2024-03-31) — Provisionand Write Offof Assets: 39540000.00
LXCHEM.NS cash_flow (annual, 2024-03-31) — Purchase Of Business: 0.00
LXCHEM.NS cash_flow (annual, 2024-03-31) — Purchase Of Investment: -13441680000.00
LXCHEM.NS balance_sheet (annual, 2024-03-31) — Raw Materials: 2129650000.00
LXCHEM.NS income_statement (annual, 2024-03-31) — Reconciled Cost Of Revenue: 19838230000.00
LXCHEM.NS income_statement (annual, 2024-03-31) — Reconciled Depreciation: 1076080000.00
LXCHEM.NS income_statement (annual, 2024-03-31) — Rent And Landing Fees: 15660000.00
LXCHEM.NS income_statement (annual, 2024-03-31) — Rent Expense Supplemental: 15660000.00
LXCHEM.NS cash_flow (annual, 2024-03-31) — Repayment Of Debt: -96600000.00
LXCHEM.NS balance_sheet (annual, 2024-03-31) — Restricted Cash: 193200000.00
LXCHEM.NS balance_sheet (annual, 2024-03-31) — Retained Earnings: 9437370000.00
LXCHEM.NS cash_flow (annual, 2024-03-31) — Sale Of Investment: 10893220000.00
LXCHEM.NS cash_flow (annual, 2024-03-31) — Sale Of PPE: 1870000.00
LXCHEM.NS income_statement (annual, 2024-03-31) — Selling And Marketing Expense: 546770000.00
LXCHEM.NS income_statement (annual, 2024-03-31) — Selling General And Administration: 1080560000.00
LXCHEM.NS balance_sheet (annual, 2024-03-31) — Share Issued: 275780785.00
LXCHEM.NS cash_flow (annual, 2024-03-31) — Short Term Debt Payments: -2515650000.00
LXCHEM.NS income_statement (annual, 2024-03-31) — Special Income Charges: 161280000.00
LXCHEM.NS cash_flow (annual, 2024-03-31) — Stock Based Compensation: 168430000.00
LXCHEM.NS balance_sheet (annual, 2024-03-31) — Stockholders Equity: 17976210000.00
LXCHEM.NS balance_sheet (annual, 2024-03-31) — Tangible Book Value: 17963030000.00
LXCHEM.NS income_statement (annual, 2024-03-31) — Tax Effect Of Unusual Items: 60190171.84
LXCHEM.NS income_statement (annual, 2024-03-31) — Tax Provision: 502600000.00
LXCHEM.NS income_statement (annual, 2024-03-31) — Tax Rate For Calcs: 0.29
LXCHEM.NS cash_flow (annual, 2024-03-31) — Taxes Refund Paid: -370690000.00
LXCHEM.NS balance_sheet (annual, 2024-03-31) — Total Assets: 28272210000.00
LXCHEM.NS balance_sheet (annual, 2024-03-31) — Total Capitalization: 18948450000.00
LXCHEM.NS balance_sheet (annual, 2024-03-31) — Total Debt: 1427840000.00
LXCHEM.NS balance_sheet (annual, 2024-03-31) — Total Equity Gross Minority Interest: 17979920000.00
LXCHEM.NS income_statement (annual, 2024-03-31) — Total Expenses: 26911790000.00
LXCHEM.NS balance_sheet (annual, 2024-03-31) — Total Liabilities Net Minority Interest: 10292290000.00
LXCHEM.NS balance_sheet (annual, 2024-03-31) — Total Non Current Assets: 13499850000.00
LXCHEM.NS balance_sheet (annual, 2024-03-31) — Total Non Current Liabilities Net Minority Interest: 1381010000.00
LXCHEM.NS income_statement (annual, 2024-03-31) — Total Other Finance Cost: 4730000.00
LXCHEM.NS balance_sheet (annual, 2024-03-31) — Total Tax Payable: 78200000.00
LXCHEM.NS income_statement (annual, 2024-03-31) — Total Unusual Items: 204540000.00
LXCHEM.NS income_statement (annual, 2024-03-31) — Total Unusual Items Excluding Goodwill: 204540000.00
LXCHEM.NS balance_sheet (annual, 2024-03-31) — Treasury Shares Number: 0.00
LXCHEM.NS balance_sheet (annual, 2024-03-31) — Work In Process: 57180000.00
LXCHEM.NS balance_sheet (annual, 2024-03-31) — Working Capital: 5861080000.00
LXCHEM.NS income_statement (annual, 2024-03-31) — Write Off: 71830000.00
LXCHEM.NS balance_sheet (quarterly, 2024-09-30) — Accounts Payable: 6276310000.00
LXCHEM.NS balance_sheet (quarterly, 2024-09-30) — Accounts Receivable: 5665150000.00
LXCHEM.NS balance_sheet (quarterly, 2024-09-30) — Available For Sale Securities: 150170000.00
LXCHEM.NS balance_sheet (quarterly, 2024-09-30) — Capital Lease Obligations: 57360000.00
LXCHEM.NS balance_sheet (quarterly, 2024-09-30) — Capital Stock: 562580000.00
LXCHEM.NS balance_sheet (quarterly, 2024-09-30) — Cash And Cash Equivalents: 448060000.00
LXCHEM.NS balance_sheet (quarterly, 2024-09-30) — Cash Cash Equivalents And Short Term Investments: 3432260000.00
LXCHEM.NS balance_sheet (quarterly, 2024-09-30) — Common Stock: 562580000.00
LXCHEM.NS balance_sheet (quarterly, 2024-09-30) — Common Stock Equity: 18561700000.00
LXCHEM.NS balance_sheet (quarterly, 2024-09-30) — Construction In Progress: 5016080000.00
LXCHEM.NS balance_sheet (quarterly, 2024-09-30) — Current Assets: 13775890000.00
LXCHEM.NS balance_sheet (quarterly, 2024-09-30) — Current Capital Lease Obligation: 6260000.00
LXCHEM.NS balance_sheet (quarterly, 2024-09-30) — Current Debt: 1139520000.00
LXCHEM.NS balance_sheet (quarterly, 2024-09-30) — Current Debt And Capital Lease Obligation: 1145780000.00
LXCHEM.NS balance_sheet (quarterly, 2024-09-30) — Current Liabilities: 8568720000.00
LXCHEM.NS balance_sheet (quarterly, 2024-09-30) — Current Provisions: 58980000.00
LXCHEM.NS balance_sheet (quarterly, 2024-09-30) — Goodwill And Other Intangible Assets: 11680000.00
LXCHEM.NS balance_sheet (quarterly, 2024-09-30) — Gross PPE: 14044430000.00
LXCHEM.NS balance_sheet (quarterly, 2024-09-30) — Inventory: 3249290000.00
LXCHEM.NS balance_sheet (quarterly, 2024-09-30) — Invested Capital: 20507880000.00
LXCHEM.NS balance_sheet (quarterly, 2024-09-30) — Investmentin Financial Assets: 150170000.00
LXCHEM.NS balance_sheet (quarterly, 2024-09-30) — Long Term Capital Lease Obligation: 51100000.00
LXCHEM.NS balance_sheet (quarterly, 2024-09-30) — Long Term Debt: 806660000.00
LXCHEM.NS balance_sheet (quarterly, 2024-09-30) — Long Term Debt And Capital Lease Obligation: 857760000.00
LXCHEM.NS balance_sheet (quarterly, 2024-09-30) — Long Term Provisions: 69680000.00
LXCHEM.NS balance_sheet (quarterly, 2024-09-30) — Minority Interest: 3410000.00
LXCHEM.NS income_statement (quarterly, 2024-09-30) — Minority Interests: 0.00
LXCHEM.NS balance_sheet (quarterly, 2024-09-30) — Net Debt: 1498120000.00
LXCHEM.NS balance_sheet (quarterly, 2024-09-30) — Net PPE: 14044430000.00
LXCHEM.NS balance_sheet (quarterly, 2024-09-30) — Net Tangible Assets: 18550020000.00
LXCHEM.NS balance_sheet (quarterly, 2024-09-30) — Non Current Deferred Taxes Liabilities: 218550000.00
LXCHEM.NS balance_sheet (quarterly, 2024-09-30) — Ordinary Shares Number: 276564003.00
LXCHEM.NS balance_sheet (quarterly, 2024-09-30) — Other Current Assets: 1429190000.00
LXCHEM.NS balance_sheet (quarterly, 2024-09-30) — Other Current Liabilities: 111110000.00
LXCHEM.NS balance_sheet (quarterly, 2024-09-30) — Other Equity Interest: 17999120000.00
LXCHEM.NS balance_sheet (quarterly, 2024-09-30) — Other Intangible Assets: 11680000.00
LXCHEM.NS balance_sheet (quarterly, 2024-09-30) — Other Non Current Assets: 272020000.00
LXCHEM.NS balance_sheet (quarterly, 2024-09-30) — Other Properties: 9028350000.00
LXCHEM.NS balance_sheet (quarterly, 2024-09-30) — Other Short Term Investments: 2984200000.00
LXCHEM.NS balance_sheet (quarterly, 2024-09-30) — Payables: 6778160000.00
LXCHEM.NS balance_sheet (quarterly, 2024-09-30) — Share Issued: 276564003.00
LXCHEM.NS balance_sheet (quarterly, 2024-09-30) — Stockholders Equity: 18561700000.00
LXCHEM.NS balance_sheet (quarterly, 2024-09-30) — Tangible Book Value: 18550020000.00
LXCHEM.NS balance_sheet (quarterly, 2024-09-30) — Total Assets: 28279820000.00
LXCHEM.NS balance_sheet (quarterly, 2024-09-30) — Total Capitalization: 19368360000.00
LXCHEM.NS balance_sheet (quarterly, 2024-09-30) — Total Debt: 2003540000.00
LXCHEM.NS balance_sheet (quarterly, 2024-09-30) — Total Equity Gross Minority Interest: 18565110000.00
LXCHEM.NS balance_sheet (quarterly, 2024-09-30) — Total Liabilities Net Minority Interest: 9714710000.00
LXCHEM.NS balance_sheet (quarterly, 2024-09-30) — Total Non Current Assets: 14503930000.00
LXCHEM.NS balance_sheet (quarterly, 2024-09-30) — Total Non Current Liabilities Net Minority Interest: 1145990000.00
LXCHEM.NS balance_sheet (quarterly, 2024-09-30) — Total Tax Payable: 501850000.00
LXCHEM.NS balance_sheet (quarterly, 2024-09-30) — Working Capital: 5207170000.00
LXCHEM.NS income_statement (quarterly, 2024-12-31) — +Operating Expense: 2168330000.00
LXCHEM.NS income_statement (quarterly, 2024-12-31) — +Total Revenue: 7863350000.00
LXCHEM.NS income_statement (quarterly, 2024-12-31) — Basic Average Shares: 276490566.00
LXCHEM.NS income_statement (quarterly, 2024-12-31) — Basic EPS: 1.06
LXCHEM.NS income_statement (quarterly, 2024-12-31) — Cost Of Revenue: 5259240000.00
LXCHEM.NS income_statement (quarterly, 2024-12-31) — Depreciation And Amortization In Income Statement: 311850000.00
LXCHEM.NS income_statement (quarterly, 2024-12-31) — Depreciation Income Statement: 311850000.00
LXCHEM.NS income_statement (quarterly, 2024-12-31) — Diluted Average Shares: 279123810.00
LXCHEM.NS income_statement (quarterly, 2024-12-31) — Diluted EPS: 1.05
LXCHEM.NS income_statement (quarterly, 2024-12-31) — Diluted NI Availto Com Stockholders: 293080000.00
LXCHEM.NS income_statement (quarterly, 2024-12-31) — EBIT: 492110000.00
LXCHEM.NS income_statement (quarterly, 2024-12-31) — EBITDA: 803960000.00
LXCHEM.NS income_statement (quarterly, 2024-12-31) — Gross Profit: 2604110000.00
LXCHEM.NS income_statement (quarterly, 2024-12-31) — Interest Expense: 21580000.00
LXCHEM.NS income_statement (quarterly, 2024-12-31) — Interest Expense Non Operating: 21580000.00
LXCHEM.NS income_statement (quarterly, 2024-12-31) — Minority Interests: 0.00
LXCHEM.NS income_statement (quarterly, 2024-12-31) — Net Income: 293080000.00
LXCHEM.NS income_statement (quarterly, 2024-12-31) — Net Income Common Stockholders: 293080000.00
LXCHEM.NS income_statement (quarterly, 2024-12-31) — Net Income Continuous Operations: 293080000.00
LXCHEM.NS income_statement (quarterly, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 293080000.00
LXCHEM.NS income_statement (quarterly, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 293080000.00
LXCHEM.NS income_statement (quarterly, 2024-12-31) — Net Income Including Noncontrolling Interests: 293080000.00
LXCHEM.NS income_statement (quarterly, 2024-12-31) — Net Interest Income: -21580000.00
LXCHEM.NS income_statement (quarterly, 2024-12-31) — Net Non Operating Interest Income Expense: -21580000.00
LXCHEM.NS income_statement (quarterly, 2024-12-31) — Normalized EBITDA: 803960000.00
LXCHEM.NS income_statement (quarterly, 2024-12-31) — Normalized Income: 293080000.00
LXCHEM.NS income_statement (quarterly, 2024-12-31) — Operating Income: 435780000.00
LXCHEM.NS income_statement (quarterly, 2024-12-31) — Operating Revenue: 7863350000.00
LXCHEM.NS income_statement (quarterly, 2024-12-31) — Other Non Operating Income Expenses: 56330000.00
LXCHEM.NS income_statement (quarterly, 2024-12-31) — Other Operating Expenses: 1511310000.00
LXCHEM.NS income_statement (quarterly, 2024-12-31) — Otherunder Preferred Stock Dividend: 0.00
LXCHEM.NS income_statement (quarterly, 2024-12-31) — Pretax Income: 470530000.00
LXCHEM.NS income_statement (quarterly, 2024-12-31) — Reconciled Cost Of Revenue: 5259240000.00
LXCHEM.NS income_statement (quarterly, 2024-12-31) — Reconciled Depreciation: 311850000.00
LXCHEM.NS income_statement (quarterly, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
LXCHEM.NS income_statement (quarterly, 2024-12-31) — Tax Provision: 177450000.00
LXCHEM.NS income_statement (quarterly, 2024-12-31) — Tax Rate For Calcs: 0.38
LXCHEM.NS income_statement (quarterly, 2024-12-31) — Total Expenses: 7427570000.00
LXCHEM.NS income_statement (annual, 2025-03-31) — +Operating Expense: 7893210000.00
LXCHEM.NS income_statement (quarterly, 2025-03-31) — +Operating Expense: 2263060000.00
LXCHEM.NS income_statement (annual, 2025-03-31) — +Total Revenue: 29770320000.00
LXCHEM.NS income_statement (quarterly, 2025-03-31) — +Total Revenue: 7096870000.00
LXCHEM.NS balance_sheet (annual, 2025-03-31) — Accounts Payable: 6971650000.00
LXCHEM.NS balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 6971650000.00
LXCHEM.NS balance_sheet (annual, 2025-03-31) — Accounts Receivable: 5379490000.00
LXCHEM.NS balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 5379490000.00
LXCHEM.NS balance_sheet (annual, 2025-03-31) — Accumulated Depreciation: -5295190000.00
LXCHEM.NS balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -5295190000.00
LXCHEM.NS balance_sheet (annual, 2025-03-31) — Additional Paid In Capital: 7939570000.00
LXCHEM.NS balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 7939570000.00
LXCHEM.NS balance_sheet (annual, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -49830000.00
LXCHEM.NS balance_sheet (quarterly, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -49830000.00
LXCHEM.NS income_statement (annual, 2025-03-31) — Amortization: 6460000.00
LXCHEM.NS cash_flow (annual, 2025-03-31) — Amortization Cash Flow: 6460000.00
LXCHEM.NS balance_sheet (annual, 2025-03-31) — Available For Sale Securities: 470000.00
LXCHEM.NS balance_sheet (quarterly, 2025-03-31) — Available For Sale Securities: 470000.00
LXCHEM.NS income_statement (annual, 2025-03-31) — Basic Average Shares: 276606606.00
LXCHEM.NS income_statement (quarterly, 2025-03-31) — Basic Average Shares: 275430380.00
LXCHEM.NS income_statement (annual, 2025-03-31) — Basic EPS: 4.10
LXCHEM.NS income_statement (quarterly, 2025-03-31) — Basic EPS: 0.79
LXCHEM.NS cash_flow (annual, 2025-03-31) — Beginning Cash Position: 1111390000.00
LXCHEM.NS balance_sheet (annual, 2025-03-31) — Buildings And Improvements: 3472850000.00
LXCHEM.NS balance_sheet (quarterly, 2025-03-31) — Buildings And Improvements: 3472850000.00
LXCHEM.NS cash_flow (annual, 2025-03-31) — Capital Expenditure: -3941110000.00
LXCHEM.NS cash_flow (annual, 2025-03-31) — Capital Expenditure Reported: -3941110000.00
LXCHEM.NS balance_sheet (annual, 2025-03-31) — Capital Lease Obligations: 43870000.00
LXCHEM.NS balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 43870000.00
LXCHEM.NS balance_sheet (annual, 2025-03-31) — Capital Stock: 554050000.00
LXCHEM.NS balance_sheet (quarterly, 2025-03-31) — Capital Stock: 554050000.00
LXCHEM.NS balance_sheet (annual, 2025-03-31) — Cash And Cash Equivalents: 416370000.00
LXCHEM.NS balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 416370000.00
LXCHEM.NS balance_sheet (annual, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 2615570000.00
LXCHEM.NS balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 2615570000.00
LXCHEM.NS cash_flow (annual, 2025-03-31) — Cash Dividends Paid: -165940000.00
LXCHEM.NS balance_sheet (annual, 2025-03-31) — Cash Equivalents: 0.00
LXCHEM.NS balance_sheet (quarterly, 2025-03-31) — Cash Equivalents: 0.00
LXCHEM.NS balance_sheet (annual, 2025-03-31) — Cash Financial: 416370000.00
LXCHEM.NS balance_sheet (quarterly, 2025-03-31) — Cash Financial: 416370000.00
LXCHEM.NS cash_flow (annual, 2025-03-31) — Change In Inventory: -946520000.00
LXCHEM.NS cash_flow (annual, 2025-03-31) — Change In Other Current Assets: -602610000.00
LXCHEM.NS cash_flow (annual, 2025-03-31) — Change In Other Current Liabilities: 133490000.00
LXCHEM.NS cash_flow (annual, 2025-03-31) — Change In Payable: -700530000.00
LXCHEM.NS cash_flow (annual, 2025-03-31) — Change In Receivables: 441840000.00
LXCHEM.NS cash_flow (annual, 2025-03-31) — Change In Working Capital: -1656740000.00
LXCHEM.NS cash_flow (annual, 2025-03-31) — Changes In Cash: -695020000.00
LXCHEM.NS balance_sheet (annual, 2025-03-31) — Common Stock: 554050000.00
LXCHEM.NS balance_sheet (quarterly, 2025-03-31) — Common Stock: 554050000.00
LXCHEM.NS cash_flow (annual, 2025-03-31) — Common Stock Dividend Paid: -165940000.00
LXCHEM.NS balance_sheet (annual, 2025-03-31) — Common Stock Equity: 19066750000.00
LXCHEM.NS balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 19066750000.00
LXCHEM.NS cash_flow (annual, 2025-03-31) — Common Stock Issuance: 100420000.00
LXCHEM.NS balance_sheet (annual, 2025-03-31) — Construction In Progress: 4485310000.00
LXCHEM.NS balance_sheet (quarterly, 2025-03-31) — Construction In Progress: 4485310000.00
LXCHEM.NS income_statement (annual, 2025-03-31) — Cost Of Revenue: 20130490000.00
LXCHEM.NS income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 4638980000.00
LXCHEM.NS balance_sheet (annual, 2025-03-31) — Current Assets: 14107230000.00
LXCHEM.NS balance_sheet (quarterly, 2025-03-31) — Current Assets: 14107230000.00
LXCHEM.NS balance_sheet (annual, 2025-03-31) — Current Capital Lease Obligation: 16820000.00
LXCHEM.NS balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 16820000.00
LXCHEM.NS balance_sheet (annual, 2025-03-31) — Current Debt: 2106710000.00
LXCHEM.NS balance_sheet (quarterly, 2025-03-31) — Current Debt: 2106710000.00
LXCHEM.NS balance_sheet (annual, 2025-03-31) — Current Debt And Capital Lease Obligation: 2123530000.00
LXCHEM.NS balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 2123530000.00
LXCHEM.NS balance_sheet (annual, 2025-03-31) — Current Deferred Taxes Liabilities: 348310000.00
LXCHEM.NS balance_sheet (quarterly, 2025-03-31) — Current Deferred Taxes Liabilities: 348310000.00
LXCHEM.NS balance_sheet (annual, 2025-03-31) — Current Liabilities: 10524220000.00
LXCHEM.NS balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 10524220000.00
LXCHEM.NS balance_sheet (annual, 2025-03-31) — Current Provisions: 59860000.00
LXCHEM.NS balance_sheet (quarterly, 2025-03-31) — Current Provisions: 59860000.00
LXCHEM.NS cash_flow (annual, 2025-03-31) — Depreciation: 1233790000.00
LXCHEM.NS cash_flow (annual, 2025-03-31) — Depreciation And Amortization: 1240250000.00
LXCHEM.NS income_statement (annual, 2025-03-31) — Depreciation And Amortization In Income Statement: 1240250000.00
LXCHEM.NS income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 395120000.00
LXCHEM.NS income_statement (annual, 2025-03-31) — Depreciation Income Statement: 1233790000.00
LXCHEM.NS income_statement (quarterly, 2025-03-31) — Depreciation Income Statement: 395120000.00
LXCHEM.NS income_statement (annual, 2025-03-31) — Diluted Average Shares: 278975783.00
LXCHEM.NS income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 275430380.00
LXCHEM.NS income_statement (annual, 2025-03-31) — Diluted EPS: 4.07
LXCHEM.NS income_statement (quarterly, 2025-03-31) — Diluted EPS: 0.79
LXCHEM.NS income_statement (annual, 2025-03-31) — Diluted NI Availto Com Stockholders: 1135040000.00
LXCHEM.NS income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 217590000.00
LXCHEM.NS income_statement (annual, 2025-03-31) — EBIT: 1807760000.00
LXCHEM.NS income_statement (quarterly, 2025-03-31) — EBIT: 205790000.00
LXCHEM.NS income_statement (annual, 2025-03-31) — EBITDA: 3048010000.00
LXCHEM.NS income_statement (quarterly, 2025-03-31) — EBITDA: 600910000.00
LXCHEM.NS cash_flow (annual, 2025-03-31) — End Cash Position: 416370000.00
LXCHEM.NS cash_flow (annual, 2025-03-31) — Financing Cash Flow: 901220000.00
LXCHEM.NS balance_sheet (annual, 2025-03-31) — Finished Goods: 1002830000.00
LXCHEM.NS balance_sheet (quarterly, 2025-03-31) — Finished Goods: 1002830000.00
LXCHEM.NS cash_flow (annual, 2025-03-31) — Free Cash Flow: -2861520000.00
LXCHEM.NS cash_flow (annual, 2025-03-31) — Gain Loss On Investment Securities: -119680000.00
LXCHEM.NS cash_flow (annual, 2025-03-31) — Gain Loss On Sale Of PPE: 67620000.00
LXCHEM.NS income_statement (annual, 2025-03-31) — General And Administrative Expense: 424330000.00
LXCHEM.NS balance_sheet (annual, 2025-03-31) — Goodwill And Other Intangible Assets: 8470000.00
LXCHEM.NS balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 8470000.00
LXCHEM.NS balance_sheet (annual, 2025-03-31) — Gross Accounts Receivable: 5429320000.00
LXCHEM.NS balance_sheet (quarterly, 2025-03-31) — Gross Accounts Receivable: 5429320000.00
LXCHEM.NS balance_sheet (annual, 2025-03-31) — Gross PPE: 21436850000.00
LXCHEM.NS balance_sheet (quarterly, 2025-03-31) — Gross PPE: 21436850000.00
LXCHEM.NS income_statement (annual, 2025-03-31) — Gross Profit: 9639830000.00
LXCHEM.NS income_statement (quarterly, 2025-03-31) — Gross Profit: 2457890000.00
LXCHEM.NS income_statement (annual, 2025-03-31) — Interest Expense: 202530000.00
LXCHEM.NS income_statement (quarterly, 2025-03-31) — Interest Expense: 73390000.00
LXCHEM.NS income_statement (annual, 2025-03-31) — Interest Expense Non Operating: 202530000.00
LXCHEM.NS income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 73390000.00
LXCHEM.NS income_statement (annual, 2025-03-31) — Interest Income: 84790000.00
LXCHEM.NS income_statement (annual, 2025-03-31) — Interest Income Non Operating: 84790000.00
LXCHEM.NS cash_flow (annual, 2025-03-31) — Interest Paid Cff: -180710000.00
LXCHEM.NS cash_flow (annual, 2025-03-31) — Interest Received Cfi: 69600000.00
LXCHEM.NS balance_sheet (annual, 2025-03-31) — Inventory: 3779880000.00
LXCHEM.NS balance_sheet (quarterly, 2025-03-31) — Inventory: 3779880000.00
LXCHEM.NS balance_sheet (annual, 2025-03-31) — Invested Capital: 21598460000.00
LXCHEM.NS balance_sheet (quarterly, 2025-03-31) — Invested Capital: 21598460000.00
LXCHEM.NS cash_flow (annual, 2025-03-31) — Investing Cash Flow: -2675830000.00
LXCHEM.NS balance_sheet (annual, 2025-03-31) — Investmentin Financial Assets: 470000.00
LXCHEM.NS balance_sheet (quarterly, 2025-03-31) — Investmentin Financial Assets: 470000.00
LXCHEM.NS balance_sheet (annual, 2025-03-31) — Investmentsin Associatesat Cost: 27620000.00
LXCHEM.NS balance_sheet (quarterly, 2025-03-31) — Investmentsin Associatesat Cost: 27620000.00
LXCHEM.NS cash_flow (annual, 2025-03-31) — Issuance Of Capital Stock: 100420000.00
LXCHEM.NS cash_flow (annual, 2025-03-31) — Issuance Of Debt: 500000000.00
LXCHEM.NS balance_sheet (annual, 2025-03-31) — Land And Improvements: 1808630000.00
LXCHEM.NS balance_sheet (quarterly, 2025-03-31) — Land And Improvements: 1808630000.00
LXCHEM.NS balance_sheet (annual, 2025-03-31) — Long Term Capital Lease Obligation: 27050000.00
LXCHEM.NS balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 27050000.00
LXCHEM.NS balance_sheet (annual, 2025-03-31) — Long Term Debt: 425000000.00
LXCHEM.NS balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 425000000.00
LXCHEM.NS balance_sheet (annual, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 452050000.00
LXCHEM.NS balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 452050000.00
LXCHEM.NS cash_flow (annual, 2025-03-31) — Long Term Debt Issuance: 500000000.00
LXCHEM.NS cash_flow (annual, 2025-03-31) — Long Term Debt Payments: -1303400000.00
LXCHEM.NS balance_sheet (annual, 2025-03-31) — Long Term Equity Investment: 27620000.00
LXCHEM.NS balance_sheet (quarterly, 2025-03-31) — Long Term Equity Investment: 27620000.00
LXCHEM.NS balance_sheet (annual, 2025-03-31) — Long Term Provisions: 62200000.00
LXCHEM.NS balance_sheet (quarterly, 2025-03-31) — Long Term Provisions: 62200000.00
LXCHEM.NS balance_sheet (annual, 2025-03-31) — Machinery Furniture Equipment: 11647750000.00
LXCHEM.NS balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 11647750000.00
LXCHEM.NS balance_sheet (annual, 2025-03-31) — Minority Interest: 3410000.00
LXCHEM.NS balance_sheet (quarterly, 2025-03-31) — Minority Interest: 3410000.00
LXCHEM.NS income_statement (annual, 2025-03-31) — Minority Interests: 0.00
LXCHEM.NS income_statement (quarterly, 2025-03-31) — Minority Interests: 0.00
LXCHEM.NS cash_flow (annual, 2025-03-31) — Net Common Stock Issuance: 100420000.00
LXCHEM.NS balance_sheet (annual, 2025-03-31) — Net Debt: 2115340000.00
LXCHEM.NS balance_sheet (quarterly, 2025-03-31) — Net Debt: 2115340000.00
LXCHEM.NS cash_flow (annual, 2025-03-31) — Net Foreign Currency Exchange Gain Loss: 71790000.00
LXCHEM.NS income_statement (annual, 2025-03-31) — Net Income: 1135040000.00
LXCHEM.NS income_statement (quarterly, 2025-03-31) — Net Income: 217590000.00
LXCHEM.NS income_statement (annual, 2025-03-31) — Net Income Common Stockholders: 1135040000.00
LXCHEM.NS income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 217590000.00
LXCHEM.NS income_statement (annual, 2025-03-31) — Net Income Continuous Operations: 1135040000.00
LXCHEM.NS income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 217590000.00
LXCHEM.NS income_statement (annual, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 1135040000.00
LXCHEM.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 217590000.00
LXCHEM.NS income_statement (annual, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 1135040000.00
LXCHEM.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 217590000.00
LXCHEM.NS cash_flow (annual, 2025-03-31) — Net Income From Continuing Operations: 1605230000.00
LXCHEM.NS income_statement (annual, 2025-03-31) — Net Income Including Noncontrolling Interests: 1135040000.00
LXCHEM.NS income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 217590000.00
LXCHEM.NS income_statement (annual, 2025-03-31) — Net Interest Income: -119730000.00
LXCHEM.NS income_statement (quarterly, 2025-03-31) — Net Interest Income: -73390000.00
LXCHEM.NS cash_flow (annual, 2025-03-31) — Net Investment Purchase And Sale: 1194830000.00
LXCHEM.NS cash_flow (annual, 2025-03-31) — Net Issuance Payments Of Debt: 1174250000.00
LXCHEM.NS cash_flow (annual, 2025-03-31) — Net Long Term Debt Issuance: -803400000.00
LXCHEM.NS income_statement (annual, 2025-03-31) — Net Non Operating Interest Income Expense: -119730000.00
LXCHEM.NS income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -73390000.00
LXCHEM.NS cash_flow (annual, 2025-03-31) — Net Other Financing Charges: -300000.00
LXCHEM.NS cash_flow (annual, 2025-03-31) — Net Other Investing Changes: 1298200000.00
LXCHEM.NS balance_sheet (annual, 2025-03-31) — Net PPE: 16141660000.00
LXCHEM.NS balance_sheet (quarterly, 2025-03-31) — Net PPE: 16141660000.00
LXCHEM.NS cash_flow (annual, 2025-03-31) — Net PPE Purchase And Sale: 850000.00
LXCHEM.NS cash_flow (annual, 2025-03-31) — Net Short Term Debt Issuance: 1977650000.00
LXCHEM.NS balance_sheet (annual, 2025-03-31) — Net Tangible Assets: 19058280000.00
LXCHEM.NS balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 19058280000.00
LXCHEM.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Taxes Assets: 0.00
LXCHEM.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Assets: 0.00
LXCHEM.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Taxes Liabilities: 337200000.00
LXCHEM.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 337200000.00
LXCHEM.NS balance_sheet (annual, 2025-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 62200000.00
LXCHEM.NS balance_sheet (quarterly, 2025-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 62200000.00
LXCHEM.NS balance_sheet (annual, 2025-03-31) — Non Current Prepaid Assets: 156190000.00
LXCHEM.NS balance_sheet (quarterly, 2025-03-31) — Non Current Prepaid Assets: 156190000.00
LXCHEM.NS income_statement (annual, 2025-03-31) — Normalized EBITDA: 3012120000.00
LXCHEM.NS income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 600910000.00
LXCHEM.NS income_statement (annual, 2025-03-31) — Normalized Income: 1109662586.42
LXCHEM.NS income_statement (quarterly, 2025-03-31) — Normalized Income: 217590000.00
LXCHEM.NS cash_flow (annual, 2025-03-31) — Operating Cash Flow: 1079590000.00
LXCHEM.NS income_statement (annual, 2025-03-31) — Operating Income: 1746620000.00
LXCHEM.NS income_statement (quarterly, 2025-03-31) — Operating Income: 194830000.00
LXCHEM.NS income_statement (annual, 2025-03-31) — Operating Revenue: 29770320000.00
LXCHEM.NS income_statement (quarterly, 2025-03-31) — Operating Revenue: 7096870000.00
LXCHEM.NS balance_sheet (annual, 2025-03-31) — Ordinary Shares Number: 277023813.00
LXCHEM.NS balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 277023813.00
LXCHEM.NS balance_sheet (annual, 2025-03-31) — Other Current Assets: 10000.00
LXCHEM.NS balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 10000.00
LXCHEM.NS balance_sheet (annual, 2025-03-31) — Other Current Liabilities: 27600000.00
LXCHEM.NS balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 27600000.00
LXCHEM.NS balance_sheet (annual, 2025-03-31) — Other Equity Interest: 65140000.00
LXCHEM.NS balance_sheet (quarterly, 2025-03-31) — Other Equity Interest: 65140000.00
LXCHEM.NS balance_sheet (annual, 2025-03-31) — Other Intangible Assets: 8470000.00
LXCHEM.NS balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 8470000.00
LXCHEM.NS balance_sheet (annual, 2025-03-31) — Other Inventories: 18140000.00
LXCHEM.NS balance_sheet (quarterly, 2025-03-31) — Other Inventories: 18140000.00
LXCHEM.NS cash_flow (annual, 2025-03-31) — Other Non Cash Items: 105970000.00
LXCHEM.NS balance_sheet (annual, 2025-03-31) — Other Non Current Assets: 550480000.00
LXCHEM.NS balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 550480000.00
LXCHEM.NS income_statement (annual, 2025-03-31) — Other Non Operating Income Expenses: 4160000.00
LXCHEM.NS income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 10960000.00
LXCHEM.NS income_statement (annual, 2025-03-31) — Other Operating Expenses: 3674770000.00
LXCHEM.NS income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 1547400000.00
LXCHEM.NS balance_sheet (annual, 2025-03-31) — Other Payable: 829030000.00
LXCHEM.NS balance_sheet (quarterly, 2025-03-31) — Other Payable: 829030000.00
LXCHEM.NS balance_sheet (annual, 2025-03-31) — Other Properties: 22310000.00
LXCHEM.NS balance_sheet (quarterly, 2025-03-31) — Other Properties: 22310000.00
LXCHEM.NS balance_sheet (annual, 2025-03-31) — Other Receivables: 298040000.00
LXCHEM.NS balance_sheet (quarterly, 2025-03-31) — Other Receivables: 298040000.00
LXCHEM.NS balance_sheet (annual, 2025-03-31) — Other Short Term Investments: 2199200000.00
LXCHEM.NS balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 2199200000.00
LXCHEM.NS income_statement (annual, 2025-03-31) — Other Special Charges: 63790000.00
LXCHEM.NS income_statement (annual, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
LXCHEM.NS income_statement (quarterly, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
LXCHEM.NS balance_sheet (annual, 2025-03-31) — Payables: 7800680000.00
LXCHEM.NS balance_sheet (quarterly, 2025-03-31) — Payables: 7800680000.00
LXCHEM.NS balance_sheet (annual, 2025-03-31) — Prepaid Assets: 2013300000.00
LXCHEM.NS balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 2013300000.00
LXCHEM.NS income_statement (annual, 2025-03-31) — Pretax Income: 1605230000.00
LXCHEM.NS income_statement (quarterly, 2025-03-31) — Pretax Income: 132400000.00
LXCHEM.NS balance_sheet (annual, 2025-03-31) — Properties: 0.00
LXCHEM.NS balance_sheet (quarterly, 2025-03-31) — Properties: 0.00
LXCHEM.NS cash_flow (annual, 2025-03-31) — Provisionand Write Offof Assets: 25760000.00
LXCHEM.NS cash_flow (annual, 2025-03-31) — Purchase Of Investment: -17907070000.00
LXCHEM.NS balance_sheet (annual, 2025-03-31) — Raw Materials: 2641070000.00
LXCHEM.NS balance_sheet (quarterly, 2025-03-31) — Raw Materials: 2641070000.00
LXCHEM.NS income_statement (annual, 2025-03-31) — Reconciled Cost Of Revenue: 20130490000.00
LXCHEM.NS income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 4638980000.00
LXCHEM.NS income_statement (annual, 2025-03-31) — Reconciled Depreciation: 1240250000.00
LXCHEM.NS income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 395120000.00
LXCHEM.NS income_statement (annual, 2025-03-31) — Rent And Landing Fees: 22730000.00
LXCHEM.NS income_statement (annual, 2025-03-31) — Rent Expense Supplemental: 22730000.00
LXCHEM.NS cash_flow (annual, 2025-03-31) — Repayment Of Debt: -1303400000.00
LXCHEM.NS balance_sheet (annual, 2025-03-31) — Restricted Cash: 20940000.00
LXCHEM.NS balance_sheet (quarterly, 2025-03-31) — Restricted Cash: 20940000.00
LXCHEM.NS balance_sheet (annual, 2025-03-31) — Retained Earnings: 10409590000.00